Atovaquone
16 NDCs across 13 manufacturers|14 Generic,2 Brand
Atovaquone is used to treat pneumocystis pneumonia and cerebral toxoplasmosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 25, 1992, and the first generic was approved Mar 18, 2014. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $42 million on Atovaquone across 88,000 claims for 26,000 beneficiaries.
Atovaquone is available as 16 NDCs from 13 manufacturers (14 generic, 2 brand), with NADAC prices from $0.72 to $6.90 per ML — the most expensive product costs about 9.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
16
14G / 2B
Manufacturers
13
competing in market
Price Spread
$0.72 – $6.90
per ML
7d Activity
avg +10.5% WoW · of 16 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
13 manufacturers producing ATOVAQUONE(3 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MEPRON 750 MG/5 ML SUSPENSION | $6.8952 per ML | — |
MEPRON 750 MG/5 ML SUSPENSION | $6.8952 per ML | — |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSPENSION CUP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP CUP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSPENSION CUP | $0.7561 per ML | +10.51% |
ATOVAQUONE 750 MG/5 ML SUSPENSION CUP | $0.7418 per ML | — |
ATOVAQUONE 750 MG/5 ML SUSP | $0.7185 per ML | — |
Frequently Asked Questions
What is Atovaquone used to treat?
Atovaquone is used to treat pneumocystis pneumonia and cerebral toxoplasmosis, per the National Library of Medicine's MED-RT classification.
When did Atovaquone become available as a generic?
FDA approved the first generic Atovaquone (ANDA) on Mar 18, 2014. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Atovaquone?
In 2024, Medicare Part D spent $42 million on Atovaquone across 88,000 claims for 26,000 beneficiaries.
How many Atovaquone products are on the market?
The Atovaquone drug market contains 16 NDCs from 13 manufacturers — 14 generic and 2 brand products.
What is the price range for Atovaquone?
NADAC reference prices for Atovaquone range from $0.7185 to $6.8952 per ML — the most expensive product costs about 9.6× the cheapest.
Is generic Atovaquone cheaper than brand?
The average generic NADAC for Atovaquone is $0.7524 per ML, versus $6.8952 for brand-labeled products — brand versions average about 9.2× the generic price.
Which manufacturers make Atovaquone?
13 manufacturers list Atovaquone in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (2), Glenmark Pharmaceuticals Inc., USA (2), PAI Holdings LLC (2), KVK-Tech Inc. (1), Camber Pharmaceuticals Inc. (1).
How has the price of Atovaquone changed recently?
Over the past 7 days, 24 Atovaquone NDCs rose and 0 fell, with a market-wide average change of +10.5%.